Global Learning Objectives
Get introduced to molecular and cellular mechanisms as related to different lysosomal functions and disease pathology and progression in LSDs,
Gain knowledge about burden/role of inflammatory pathways leading to cell death and the manifestation of LSDs,
Get introduced to the role of genomics and metabolomics approaches in precision or individualized medicine,
Gain insights into current treatment strategies and findings from preclinical studies in different model systems and clinical trials towards novel therapies,
Discuss the efficacy, safety of clinical studies involving next-generation enzyme replacement therapies that utilize hyper-mannosylation and other techniques such as antibody peptides and targeting sequences for improved tissue penetration,
Review pharmacochaperones and small molecular approaches as disease-specific or symptomatic treatment of various LSDs,
Learn about novel tools and technologies that incorporate big data and machine learning,
Discuss the clinical utility of sphingolipid and other biomarkers in the diagnosis, and therapeutic management of LSDs.
GRIDS2022 Enduring
Achievements and Disappointments: Gaucher Disease Over the Past 3 Decades
Application of Novel Technologies in Lysosomal Disorders
Biomarkers and Other Genetic/Genomic Approaches in Lysosomal Disorders
Novel and New Generation Therapies in Lysosomal Disorders
Current Clinical Management and Challenges in Lysosomal Disorders
https://checkrare.com/learning/p-grids2022-session6-current-clinical-management-and-challenges-in-lysosomal-disorders/
Basic Mechanisms and Model Systems in Lysosomal Disorders